A company that develops a product would earn a share of reward money based on its share of the health improvements achieved by all the products competing for the available funds. What is still needed, however, is sufficient reward money – perhaps $100 million from governments, NGOs, foundations and the pharmaceutical industry – to stimulate serious investment.
如今，波奇和霍利斯对他们的方案进行了微调，使其做好了进行真实世界实验的准备。开发某产品的某公司将获得一定比例的奖励金，金额基础为它在竞争可得资金的产品所取得的总健康改善成果中的所占比例。但是，仍然需要足够的奖励金——也许需要政府、非政府组织、基金会和制药业资助1亿美元——以刺激认真的投资。